Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 341 resultados

ARISE2: Career Accelerator for Research Infrastructure Scientists 2nd generation MEDIZINISCHE UNIVERSITAET WIEN participó en un HORIZON EUROPE: HORIZON-MSCA-2023-COFUND-01 The ARISE2 program will train 50 postdoctoral fellows for roles as research infrastructure (RI) scientists—highly skilled and much-needed sc...
2024-09-12 - 2029-12-31 | Financiado

DSYREKI: Dynamical Systems and Reaction Kinetics Networks The primary goal of the project is to advance the theory of dynamical systems governed by differential equations with multiple parameters, l...
2024-08-16 - 2028-08-31 | Financiado

Sonar-Cities: Social Sciences Participatory Research Action for Preparedness in Risk Management for Disasters and... Disasters, including health emergencies, pose enormous strains on response capacities of cities, countries, and the European Union, compound...
2024-08-14 - 2027-11-30 | Financiado

RadExIORSBoost: Twinning to skyrocket scientific excellence towards individual radiosensitivity prediction by raisin... MEDIZINISCHE UNIVERSITAET WIEN participó en un HORIZON EUROPE: HORIZON-WIDERA-2023-ACCESS-02 Prostate cancer patients receiving radiotherapy (RT) may develop radiation-induced side effects, which significantly impact quality of life....
2024-05-22 - 2027-09-30 | Financiado

conNEctoER: Understanding of the Membrane Connection Linking the Nucleus to the Endoplasmic Reticulum MEDIZINISCHE UNIVERSITAET WIEN tramitó un HORIZON EUROPE: ERC-2023-COG Compartmentalization into membrane-bound organelles is a key feature of all eukaryotic cells, and communication between organelles needs to...
2024-04-01 - 2029-03-31 | Financiado

PROSPER: Promoting RObust Systems biology on Patients and Experimental models with obesity-driven liveR cance... MEDIZINISCHE UNIVERSITAET WIEN tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 In obesity, pathological expansion of adipocytes leads to increased adipose tissue macrophage (ATM) amounts and adipocyte death. Adipocyte d...
2024-03-04 - 2026-12-31 | Financiado

ID-DarkMatter-NCD: Unraveling the dark matter of infectious diseases, environmental and genetic factors tipping the bal... MEDIZINISCHE UNIVERSITAET WIEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 While it is known that post-COVID-19-condition (PCC) is caused by SARS-CoV-2 infection, for most other immune-related noncommunicable diseas...
2024-01-01 - 2028-12-31 | Financiado

I-SCREEN: I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in a... MEDIZINISCHE UNIVERSITAET WIEN tramitó un HORIZON EUROPE: HORIZON-EIC-2023-PATHFINDEROPEN-01 The aim of I(eye)-Screen is to develop an artificial intelligence (AI)-based diagnostic decision support system for screening and monitoring...
2024-01-01 - 2027-12-31 | Financiado

eRaDicate: Innovative ligands for nuclear receptors to eradicate cancer relapse. MEDIZINISCHE UNIVERSITAET WIEN tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 The aim of the “eRaDicate” international, multidisciplinary, and intersectoral cancer drug research and development programme is to empower...
2024-01-01 - 2027-12-31 | Financiado

EBRAINS 2.0: EBRAINS 2.0 A Research Infrastructure to Advance Neuroscience and Brain Health MEDIZINISCHE UNIVERSITAET WIEN participó en un HORIZON EUROPE: HORIZON-INFRA-2022-SERV-B-01 EBRAINS is a collaborative European Research Infrastructure designed to advance and accelerate progress in neuroscience and brain health. Th...
2023-12-14 - 2026-12-31 | Financiado

DEFINITIVE: Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer MEDIZINISCHE UNIVERSITAET WIEN participó en un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 HER2+ breast cancer affects around 390.000 women annually worldwide (i.e. 3 patients every 4 minutes). Over the last decade, polychemotherap...
2023-12-11 - 2028-11-30 | Financiado

GLUCO-SCAN: Deuterium labeling of GLUCOse improves magnetic resonance imaging Sensitivity to CANcer metabolism MEDIZINISCHE UNIVERSITAET WIEN tramitó un HORIZON EUROPE: ERC-2022-COG The targeted scientific breakthrough of GLUCO-SCAN is the development and clinical evaluation of a disruptive whole-body molecular imaging c...
2023-12-01 - 2028-11-30 | Financiado

BETTER4U: Preventing obesity through Biologically and bEhaviorally Tailored inTERventions for you BETTER4U MEDIZINISCHE UNIVERSITAET WIEN participó en un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-two-stage BETTER4U aims at the identification and personalized management of all weight gain determinants to battle the increasingly rising numbers of...
2023-10-23 - 2027-10-31 | Financiado

OPTIMEYEZ: Optical imaging platform for high-throughput longitudinal studies of the eye in disease models MEDIZINISCHE UNIVERSITAET WIEN tramitó un HORIZON EUROPE: ERC-2022-POC1 Loss of vision is frequently related to disorders of the retina that may be either primary or secondary such as involvement in metabolic or...
2023-10-01 - 2025-03-31 | Financiado

BIOSMALL: Identification of subtype-specific biomarkers in small cell lung cancer MEDIZINISCHE UNIVERSITAET WIEN tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-SE-01 Although small cell lung cancer (SCLC) is a particularly aggressive disease, targeted therapies have remained largely unsuccessful and there...
2023-10-01 - 2027-09-30 | Financiado

IgG4-TREAT: Systematic study of IgG4-autoimmune diseases to develop new treatment strategies MEDIZINISCHE UNIVERSITAET WIEN tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 IgG4-autoimmune diseases (IgG4-AID) are rare but collectively correspond to a significant group of devastating diseases affectingmany differ...
2023-09-01 - 2027-08-31 | Financiado

BIOSMALL: Identification of subtype-specific biomarkers in small cell lung cancer MEDIZINISCHE UNIVERSITAET WIEN tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-SE-01 Although small cell lung cancer (SCLC) is a particularly aggressive disease, targeted therapies have remained largely unsuccessful and there...
2023-08-02 - 2027-09-30 | Financiado

INTERACT: Skin microbial metabolites and antimicrobial peptides at the interface of skin-gut inflammation MEDIZINISCHE UNIVERSITAET WIEN tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-PF-01 Skin diseases affect 900 million people worldwide. Despite major efforts gaining insights in the disease mechanisms underlying Atopic Dermat...
2023-07-13 - 2026-08-31 | Financiado